Square Pharmaceuticals
Square Pharmaceuticals PLC is a Bangladeshi pharmaceutical manufacturing enterprise producing prescription formulations, active ingredients, and herbal healthcare products. The company manufactures antibiotics, cardiovascular drugs, central nervous system medicines, anti-diabetic formulations, and consumer healthcare products. Main revenue drivers comprise domestic commercial sales of branded prescription pharmaceuticals alongside export sales to developing and developed markets globally. Square Pharmaceuticals serves prescription pharmacies, hospital networks, healthcare institutions, and patients across Bangladesh, Asia, Africa, and Europe. The company holds a market-leading dominant position as Bangladesh's largest pharmaceutical company with a substantial domestic market share. Headquartered in Dhaka, Bangladesh, Square Pharmaceuticals PLC is listed on the Dhaka Stock Exchange and Chittagong Stock Exchange.
2 of the funds FundTelligence covers report a position in Square Pharmaceuticals.
- Sector
- Health Care
- Country
- Bangladesh
- Funds holding it
- 2
Funds holding Square Pharmaceuticals
- Tundra Sustainable Frontier Fund — Tundra · 4.24 % (full portfolio disclosed, June 2026)
- T. Rowe Price Frontier Markets Equity Fund — T. Rowe Price · 0.77 % (full portfolio disclosed, September 2026)